firsthealthunited.org Report : Visit Site

Technical data of the firsthealthunited.org

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host firsthealthunited.org. Currently, hosted in Italy and its service provider is Register.IT Spa .

the related websites

channel4.com partstrain.com cairngorms.co.uk accliverpool.com artsaward.org.uk scandinavian-village.co.uk harewood.org if.com worldbookday.com nethouseprices.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

about us policy/beleidsplan social responsibility contact us hiv/aids state of hiv epidemic treatment and accomplishments care and take care blog first health pharma dengue project research cytokine storm learn more antivirals for the developing world we develop revolutionary new antiviral agents based on an existing portfolio of highly active pharmaceutical compounds that was granted to our organisation by our sponsor first health pharmaceuticals. we do not perform basic research which (although of great importance for scientific progress in the long run) can take decades and require enormous investments before potential new pharmaceuticals are discovered. we already possess antiviral agents with proven activity and with your help we will bring them to the patients as soon as possible. we specifically target viruses that offer limited economic perspective to the pharmaceutical industry but are of great importance to the developing world. first health united first health united is a non-profit organization based in the netherlands . we are a fully independent spin off of the company first health pharmaceuticals , who transferred the largest part of its antivirus development pipeline to our non-profit foundation. view more dengue project 3,9 billion people worldwide are at risk of dengue virus infection, for which there are no therapeutic solutions available. dengue fever progresses to severe dengue in about 500.000 patients worldwide and causes a substantial burden especially on developing countries. view more hiv-aids project first health pharmaceuticals has transferred part of its hiv translation inhibitors antiretroviral compounds, which offer unique possibilities uncommon to traditional hiv antivirals, to first health united. view more viral targets we concentrate our development on new pharmaceuticals that are active against dangerous tropical viral infections for which currently no treatment options are available. severe dengue dengue hemorrhagic fever can result in dengue shock syndrome with ebola-like symptoms, proving fatal to 22.000 patients annually. hiv/aids the battle against hiv/aids is fought on several fronts. for decades already, the hiv virus has proven to be capable of rapidly developing resistance against all the retroviral drugs that have been thrown against it. cancer targets first health pharmaceuticals also has a large oncology pipeline and in the future, the non-profit development of certain niche market cancer targets may also be transferred to first health united. tropical viruses disease spreading tiger mosquitoes are expanding their territory worldwide, invading also regions that were previously spared from tropical virus epidemics. rna helicase technology the human rna helicase ddx3 is a so-called host factor enzyme, used by several viruses during their replication within our cell apparatus. our mission we develop revolutionary new antiviral agents based on an existing portfolio of highly active pharmaceutical compounds that was granted to our organization by our sponsor first health pharmaceuticals. pharmaceutical research our mission may sound ambitious, but actually the start of the clinical development (testing in humans) of new pharmaceuticals for most of our target indications is right around the corner. with the antiviral activity and lack of toxicity of our compounds already proven against many viruses, we now largely concentrate our research on optimal delivery of our compounds in the body as well as making our compounds as effective as possible against the viral diseases at issue. a revolutionary approach inhibition of the human ddx3 rna helicase is a truly revolutionary approach in antivirus development and first health pharmaceuticals is the only company in the world working on this antivirus technology. already ten years ago a precursor of our current platform was developed by the university of siena, italy. the compounds proved active against hiv virus and eventually resulted in a completely new technology that focuses on the selective inhibition of the helicase domain of the ddx3 enzyme. blog new ebola outbreak in congo raises concern about vaccination and treatment may 8, 2019 by morava.admin in ebola 0 0 like! continue 0 comments care and take care – hiv/aids awareness campaign december 1, 2018 by morava.admin in aids 0 2 like! today on world aids day we announce the official start of our care and take care – hiv/aids awareness program, which specifically targets adolescents worldwide through our social continue 0 comments first health united presents its new hiv/aids projects december 1, 2018 by morava.admin in aids 0 0 like! on world aids day, first health united is proud to announce two important hiv/aids projects. unfortunately, hiv and aids still are a substantial problem in several developing countries. problems with late continue 0 comments first health to participate at aids2018 conference july 18, 2018 by morava.admin in aids 0 0 like! first health pharmaceuticals and first health united foundation are going to participate at aids2018, the 22nd international aids conference on hiv and aids, which will take place in rai continue 0 comments setback in dengue vaccine program highlights the urgent need for effective and free dengue antiviral agents november 30, 2017 by morava.admin in fhu 0 0 like! today it was announced that the use of the only approved dengue vaccine, dengvaxia, is to be strictly limited due to evidence it can worsen the disease in people who continue 0 comments tropical virus targets transferred to non-profit organization first health united march 27, 2017 by morava.admin in fhp 0 0 like! today the final agreement was signed through which biotech company first health pharmaceuticals transferred large part of its pipeline of highly active antivirus agents concerning tropical virus targets to the continue 0 comments first health united foundation september 9, 2016 by morava.admin in fhp 0 0 like! the first health united foundation is an independent non-profit spin off of the first health group, founded in 2015 by former mc kinsey benelux chairman and life sciences philanthropist f.w. continue 0 comments social responsibility first health pharmaceuticals took its social responsibility very serious when it donated the largest part of its antivirus pipeline to first health united. the decision is testimony to the fact that profit maximisation is clearly not the only goal of the company and that social responsibility is a driving force within the first health group. view more we are different most non-profit organisations work at a national level, gravitating towards basic research in their country of origin. first health united is different: we collaborate with whatever university is a leader in our field of research, regardless if it is in the netherlands, china, italy or the usa. view more your contribution will save lives you can contribute to the development and non-profit distribution of tangible new pharmaceuticals. © first health united - design by genialpixel - privacy & cookie policy search for:

URL analysis for firsthealthunited.org

https://firsthealthunited.org/care-and-take-care-hivaids-awareness-campaign/
http://firsthealthunited.org/dengue-project-4/
http://firsthealthunited.org/about-us/our-mission/social-responsibility/#we-are-different
https://firsthealthunited.org/hivaids/
http://firsthealthunited.org/about-us/
http://firsthealthunited.org/about-us/our-mission/social-responsibility/
https://firsthealthunited.org/first-health-united-foundation/
https://firsthealthunited.org/about-us/our-mission/
https://firsthealthunited.org/about-us/
https://firsthealthunited.org/first-health-united-presents-new-hiv-aids-projects/#comments
https://firsthealthunited.org/new-ebola-outbreak-in-congo-raises-concern-about-vaccination-and-treatment/
https://firsthealthunited.org/category/aids/
https://firsthealthunited.org/blog-post-3/
https://firsthealthunited.org/category/fhu/
https://firsthealthunited.org/contact-us/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: FIRSTHEALTHUNITED.ORG
Registry Domain ID: D402200000000369770-LROR
Registrar WHOIS Server: whois.register.it
Registrar URL: http://we.register.it
Updated Date: 2017-10-24T01:52:22Z
Creation Date: 2016-10-23T20:07:41Z
Registry Expiry Date: 2018-10-23T20:07:41Z
Registrar Registration Expiration Date:
Registrar: Register.IT SPA
Registrar IANA ID: 168
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +39.5520021555
Reseller:
Domain Status: ok https://icann.org/epp#ok
Registry Registrant ID: C184453103-LROR
Registrant Name: Jan Willem Bakker
Registrant Organization: Jan Willem Bakker
Registrant Street: Loc. San Chimento 3
Registrant City: Casole d'Elsa
Registrant State/Province: SI
Registrant Postal Code: 53031
Registrant Country: IT
Registrant Phone: +39.3347884222
Registrant Phone Ext:
Registrant Fax:
Registrant Fax Ext:
Registrant Email: [email protected]
Registry Admin ID: C184453104-LROR
Admin Name: Bakker Jan Willem
Admin Organization: Jan Willem Bakker
Admin Street: Science Park 406
Admin City: Amsterdam
Admin State/Province: NH
Admin Postal Code: 1098XH
Admin Country: NL
Admin Phone: +31.203031921
Admin Phone Ext:
Admin Fax:
Admin Fax Ext:
Admin Email: [email protected]
Registry Tech ID: C6744170-LROR
Tech Name: REGISTER.IT S.p.a.
Tech Organization: REGISTER.IT S.p.a.
Tech Street: Viale della Giovine Italia 17
Tech City: Firenze
Tech State/Province: FI
Tech Postal Code: 50122
Tech Country: IT
Tech Phone: +39.0353230300
Tech Phone Ext:
Tech Fax: +39.0353230312
Tech Fax Ext:
Tech Email: [email protected]
Name Server: NS1.REGISTER.IT
Name Server: NS2.REGISTER.IT
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2018-03-21T04:19:22Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to: (a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.

  REFERRER http://www.pir.org/

  REGISTRAR Public Interest Registry

SERVERS

  SERVER org.whois-servers.net

  ARGS firsthealthunited.org

  PORT 43

  TYPE domain

DOMAIN

  NAME firsthealthunited.org

  HANDLE D402200000000369770-LROR

  CREATED 2016-10-23

STATUS
ok https://icann.org/epp#ok

NSERVER

  NS1.REGISTER.IT 195.110.124.140

  NS2.REGISTER.IT 195.7.227.1

OWNER

  HANDLE C184453103-LROR

  NAME Jan Willem Bakker

  ORGANIZATION Jan Willem Bakker

ADDRESS

STREET
Loc. San Chimento 3

  CITY Casole d'Elsa

  STATE SI

  PCODE 53031

  COUNTRY IT

  PHONE +39.3347884222

  EMAIL [email protected]

ADMIN

  HANDLE C184453104-LROR

  NAME Bakker Jan Willem

  ORGANIZATION Jan Willem Bakker

ADDRESS

STREET
Science Park 406

  CITY Amsterdam

  STATE NH

  PCODE 1098XH

  COUNTRY NL

  PHONE +31.203031921

  EMAIL [email protected]

TECH

  HANDLE C6744170-LROR

  NAME REGISTER.IT S.p.a.

  ORGANIZATION REGISTER.IT S.p.a.

ADDRESS

STREET
Viale della Giovine Italia 17

  CITY Firenze

  STATE FI

  PCODE 50122

  COUNTRY IT

  PHONE +39.0353230300

  EMAIL [email protected]

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .